FDA Approves Bepirovirsen, First Antisense Therapy for Chronic Hepatitis B
FDA Approves Bepirovirsen, First Antisense Therapy for Chronic Hepatitis B Contagion Live
Regulatory Approvals
KACH collaboration garners FDA approval of TBI diagnosis device; device recognized by TIME
KACH collaboration garners FDA approval of TBI diagnosis device; device recognized by TIME DVIDS
FDA Approves Hibsago | PharmExec
FDA Approves Hibsago | PharmExec Pharmaceutical Executive
FDA Approval of Dostarlimab Brings Potential Organ-Sparing Approach in dMMR Locally Advanced Rectal Cancer
FDA Approval of Dostarlimab Brings Potential Organ-Sparing Approach in dMMR Locally Advanced Rectal Cancer OncLive
FDA approves Cosette’s Evoxac oral solution for Sjögren’s disease
FDA approves Cosette’s Evoxac oral solution for Sjögren’s disease Pharmaceutical Technology